European Archives of Oto-Rhino-Laryngology

, Volume 272, Issue 4, pp 971–979

Value of sentinel lymph node biopsy in papillary thyroid cancer: initial results of a prospective trial

  • R. N. Cabrera
  • C. T. Chone
  • D. Zantut-Wittmann
  • P. Matos
  • D. M. Ferreira
  • P. S. G. Pereira
  • R. J. R. Ferrari
  • A. O. Santos
  • A. N. Crespo
  • E. C. S. C. Etchebehere
Head and Neck


The objectives of the study were to evaluate the performance of sentinel lymph node biopsy (SLNB) in detecting occult metastases in papillary thyroid carcinoma (PTC) and to correlate their presence to tumor and patient characteristics. Twenty-three clinically node-negative PTC patients (21 females, mean age 48.4 years) were prospectively enrolled. Patients were submitted to sentinel lymph node (SLN) lymphoscintigraphy prior to total thyroidectomy. Ultrasound-guided peritumoral injections of 99mTc-phytate (7.4 MBq) were performed. Cervical single-photon emission computed tomography and computed tomography (SPECT/CT) images were acquired 15 min after radiotracer injection and 2 h prior to surgery. Intra-operatively, SLNs were located with a gamma probe and removed along with non-SLNs located in the same neck compartment. Papillary thyroid carcinoma, SLNs and non-SLNs were submitted to histopathology analysis. Sentinel lymph nodes were located in levels: II in 34.7 % of patients; III in 26 %; IV in 30.4 %; V in 4.3 %; VI in 82.6 % and VII in 4.3 %. Metastases in the SLN were noted in seven patients (30.4 %), in non-SLN in three patients (13.1 %), and in the lateral compartments in 20 % of patients. There were significant associations between lymph node (LN) metastases and the presence of angio-lymphatic invasion (p = 0.04), extra-thyroid extension (p = 0.03) and tumor size (p = 0.003). No correlations were noted among LN metastases and patient age, gender, stimulated thyroglobulin levels, positive surgical margins, aggressive histology and multifocal lesions. Sentinel lymph node biopsy can detect occult metastases in PTC. The risk of a metastatic SLN was associated with extra-thyroid extension, larger tumors and angio-lymphatic invasion. This may help guide future neck dissection, patient surveillance and radioiodine therapy doses.


Sentinel lymph node Papillary thyroid carcinoma Differentiated thyroid cancer SPECT/CT Sentinel lymph node biopsy Lymphoscintigraphy 


  1. 1.
    Merritt RM, Williams MF, James TH, Porubsky ES (1997) Detection of cervical metastasis: a meta-analysis comparing computed tomography with physical examination. Arch Otolaryngol Head Neck Surg 123:149–152CrossRefPubMedGoogle Scholar
  2. 2.
    Woolgar JA, Beirne JC, Vaughan ED, Lewis-Jones HG, Scott J, Brown JS (1995) Correlation of histopathologic findings with clinical and radiologic assessments of cervical lymph-node metastases in oral cancer. Int J Oral Maxillofac Surg 24:30–37CrossRefPubMedGoogle Scholar
  3. 3.
    McGuirt WF, Williams DW 3rd, Keyes JW Jr, Greven KM, Watson NE Jr, Geisinger KR, Cappellari JO (1995) A comparative diagnostic study of head and neck nodal metastases using positron emission tomography. Laryngoscope 105:373–375CrossRefPubMedGoogle Scholar
  4. 4.
    Jong RJB, Rongen RJ, Laméris JS, Harthorn M, Verwoerd CDA, Knegt P (1989) Metastatic neck disease: palpation vs. ultrasound examination. Arch Otolaryngol Head Neck Surg 115:689–690CrossRefGoogle Scholar
  5. 5.
    Haberal I, Çelik H, Göçmen H, Akmansu H, Yörük M, Özeri C (2004) Which is important in the evaluation of metastatic lymph nodes in head and neck cancer: palpation, ultrasonography, or computed tomography? Otolaryngol Head Neck Surg 130:197–201CrossRefPubMedGoogle Scholar
  6. 6.
    Watkinson JC, Franklyn JA, Olliff JF (2006) Detection and surgical treatment of cervical lymph nodes in differentiated thyroid cancer. Thyroid 16:187–194CrossRefPubMedGoogle Scholar
  7. 7.
    Kouvaraki MA, Shapiro SE, Fornage BD, Edeiken-Monro BS, Sherman SI, Vassilopoulou-Sellin R, Lee JE, Evans DB (2003) Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 134:946–954CrossRefPubMedGoogle Scholar
  8. 8.
    Stulak JM, Grant CS, Farley DR, Thompson GB, van Heerden JA, Hay ID, Reading CC, Charboneau JW (2006) Value of preoperative ultrasonography in the surgical management of initial and preoperative papillary thyroid cancer. Arch Surg 141:489–496CrossRefPubMedGoogle Scholar
  9. 9.
    Pereira JA, Jimeno J, Miquel J, Iglesias M, Munné A, Sancho JJ, Sitges-Serra A (2005) Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 138:1095–1101CrossRefPubMedGoogle Scholar
  10. 10.
    Henry JF, Gramatica L, Denizot A, Kvachenyuk A, Puccini M, Defechereux T (1998) Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbeck’s Arch Surg 383:167–169Google Scholar
  11. 11.
    Pasieka JL (2001) Sentinel lymph node biopsy in the management of thyroid disease. Br J Surg 88:321–322CrossRefPubMedGoogle Scholar
  12. 12.
    Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Glass EC, Wang HJ (2006) Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355:1307–1317CrossRefPubMedGoogle Scholar
  13. 13.
    Giuliano AE, Jones RC, Brennan M, Statman R (1997) Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15:2345–2350PubMedGoogle Scholar
  14. 14.
    Reynolds C, Mick R, Donohue JH, Grant CS, Farley DR, Callans LS, Orel SG, Keeney GL, Lawton TJ, Czerniecki BJ (1999) Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 17:1720–1726PubMedGoogle Scholar
  15. 15.
    Chone CT, Magalhães RS, Etchehebere E, Camargo E, Altemani A, Crespo AN (2008) Predictive value of sentinel node biopsy in head and neck cancer. Acta Otolaryngol 128:920–924CrossRefPubMedGoogle Scholar
  16. 16.
    Sadeghi R, Gholami H, Zakavi SR, Kakhki VR, Tabasi KT, Horenblas S (2012) Accuracy of sentinel lymph node biopsy for inguinal lymph node staging of penile squamous cell carcinoma: systematic review and meta-analysis of the literature. J Urol 187:25–31CrossRefPubMedGoogle Scholar
  17. 17.
    Hassanzade M, Attaran M, Treglia G, Yousefi Z, Sadeghi R (2013) Lymphatic mapping and sentinel node biopsy in squamous cell carcinoma of the vulva: systematic review and meta-analysis of the literature. Gynecol Oncol 130:237–245CrossRefPubMedGoogle Scholar
  18. 18.
    Kelemen PR, Van Herle AJ, Giuliano (1998) Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 133:288–292CrossRefPubMedGoogle Scholar
  19. 19.
    Pelizzo, MeranteBoschin I, Toniato A, Piotto A, Bernante P, Paggetta C, De Salvo GL, Carpi A, RubelloD, Casara D (2006) Sentinel node mapping and biopsy in thyroid cancer: a surgical perspective. Biomed Pharmacother 60:405–408CrossRefPubMedGoogle Scholar
  20. 20.
    Rettenbacher L, Sungler P, Gmeiner D, Kässmann H, Galvan G (2000) Detecting the sentinel lymph node in patients with differentiated thyroid carcinoma. Eur J Nucl Med 27:1399–1401CrossRefPubMedGoogle Scholar
  21. 21.
    Pasieka JL (2001) Sentinel lymph node biopsy in the management of thyroid disease. Br J Surg 88:321–322CrossRefPubMedGoogle Scholar
  22. 22.
    Pelizzo MR, MeranteBoschin I, Toniato A, Pagetta C, Casal Ide E, Mian C, Rubello D (2008) Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma. Minerva Endocrinol 33:359–379PubMedGoogle Scholar
  23. 23.
    Mazzaferri EL (2000) Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy. Endocr Pract 6:469–476CrossRefPubMedGoogle Scholar
  24. 24.
    Shaha AR (2000) Thyroid cancer: extent of thyroidectomy. Cancer Control 7:240–245PubMedGoogle Scholar
  25. 25.
    Scheumann GFW, Gimm O, Wegener G, Hundeshagen H (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18:559–568CrossRefPubMedGoogle Scholar
  26. 26.
    Hamming JF, van de Velde CJ, Fleuren GJ, Goslings BM (1998) Differentiated thyroid cancer: a stage adapted approach to the treatment of regional lymph node metastases. Eur J Cancer Clin Oncol 24:325–330CrossRefGoogle Scholar
  27. 27.
    Leboulleux S, Baudin E, Schlumberger M (2003) Follow-up of thyroid cancer patients with favorable prognostic indicators. Ann Endocrinol 64:64–67Google Scholar
  28. 28.
    Cibas ES, Ali SZ (2009) The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 132:658–665CrossRefPubMedGoogle Scholar
  29. 29.
    Balasubramanian SP, Harrison BJ (2011) Systematic review and meta-analysis of sentinel node biopsy in thyroid cancer. Br J Surg 98:334–344CrossRefPubMedGoogle Scholar
  30. 30.
    Kutler DI, Crummey AD, Kuhel WI (2012) Routine central compartment lymph node dissection for patients with papillary thyroid carcinoma. Head Neck 34:260–263CrossRefPubMedGoogle Scholar
  31. 31.
    Koo BS, Choi EC, Yoon YH, Kim DH, Kim EH, Lim YC (2009) Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma. Ann Surg 249:840–844CrossRefPubMedGoogle Scholar
  32. 32.
    Roh JL, Kim JM, Park CI (2011) Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence. Ann Surg Oncol 18:2245–2250CrossRefPubMedGoogle Scholar
  33. 33.
    Ito Y, Jikuzono T, Higashiyama T, Asahi S, Tomoda C, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2006) Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg 30:1821–1828CrossRefPubMedGoogle Scholar
  34. 34.
    Esteva D, Muros MA, Llamas-Elvira JM, Jiménez Alonso J, Villar JM, López de la Torre M, Muros T (2009) Clinical and pathological factors related to 18F-FDG-PET positivity in the diagnosis of recurrence and/or metastasis in patients with differentiated thyroid cancer. Ann Surg Oncol 16:2006–2013CrossRefPubMedGoogle Scholar
  35. 35.
    Adhikari LJ, Sciallis AP, Reynolds J, Jenkins S, Smith C, Stan MN, Nassar A (2013) Clinicopathologic predictors of thyroid bed recurrence of differentiated thyroid cancer using ultrasound-guided fine-needle aspiration biopsies. Thyroid 23:982–988CrossRefPubMedGoogle Scholar
  36. 36.
    Lee YS, Lim YS, Lee JC, Wang SG, Kim IJ, Lee BJ (2010) Clinical implication of the number of central lymph node metastasis in papillary thyroid carcinoma: preliminary report. World J Surg 34:2558–2563CrossRefPubMedGoogle Scholar
  37. 37.
    Mercante G, Frasoldati A, Pedroni C, Formisano D, Renna L, Piana S, GardiniG, Valcavi R, Barbieri V (2009) Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 19:707–771CrossRefPubMedGoogle Scholar
  38. 38.
    So YK, Son YI, Hong SD, Seo MY, Baek CH, Jeong HS, Chung MK (2010) Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections. Surgery 148:526–531CrossRefPubMedGoogle Scholar
  39. 39.
    Noguchi S, Noguchi A, Murakami N (1970) Papillary carcinoma of the thyroid I developing pattern of metastasis II value of prophylactic lymph node excision. Cancer 26:1053–1060CrossRefPubMedGoogle Scholar
  40. 40.
    Hamming JF, van de Velde CJH, Goslings BM, Fleuren GJ, HermansJ, Delemarre JF, van Slooten EA (1989) Preoperative diagnosis and treatment of metastases to the regional lymph nodes in papillary carcinoma of the thyroid gland. Surg Gynecol Obstet 169:107–111PubMedGoogle Scholar
  41. 41.
    Scheumann G, Gimm O, Wegener G, Hundeshagen H, Draile H (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18:559–567CrossRefPubMedGoogle Scholar
  42. 42.
    McHenry CR, Rosen IB, Walfish PG (1991) Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg 162:353–356CrossRefPubMedGoogle Scholar
  43. 43.
    Podnos YD, Smith D, Wagman LD, Ellenhorn JD (2005) The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg 71:731–734PubMedGoogle Scholar
  44. 44.
    Krag DN (1998) Minimal access surgery for staging regional lymph nodes: the sentinel node concept. Curr Probl Surg 35:951–1016CrossRefPubMedGoogle Scholar
  45. 45.
    Garcia-Burillo A, Roca Bielsa I, Gonzalez O, Zafon C, Sabate M, Castellvi J, Serres X, Iglesias C, Vilallonga R, Caubet E, Fort JM, Mesa J, Armengol M, Castell-Conesa J (2013) SPECT/CT sentinel lymph node identification in papillary thyroid cancer: lymphatic staging and surgical management improvement. Eur J Nucl Med Mol Imaging 40:1645–1655CrossRefPubMedGoogle Scholar
  46. 46.
    de Meer SG, Dauwan M, de Keizer B, Valk GD, Borel Rinkes IH, Vriens MR (2012) Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer. World J Surg 36:1262–1267CrossRefPubMedCentralPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • R. N. Cabrera
    • 1
  • C. T. Chone
    • 2
  • D. Zantut-Wittmann
    • 3
  • P. Matos
    • 4
  • D. M. Ferreira
    • 5
  • P. S. G. Pereira
    • 2
  • R. J. R. Ferrari
    • 1
  • A. O. Santos
    • 1
  • A. N. Crespo
    • 2
  • E. C. S. C. Etchebehere
    • 1
  1. 1.Division of Nuclear Medicine, Department of RadiologyCampinas State University (UNICAMP)CampinasBrazil
  2. 2.Department of OtorhinolaryngologyCampinas State University (UNICAMP)CampinasBrazil
  3. 3.Division of EndocrinologyCampinas State University (UNICAMP)CampinasBrazil
  4. 4.Department of PathologyCampinas State University (UNICAMP)CampinasBrazil
  5. 5.Department of RadiologyCampinas State University (UNICAMP)CampinasBrazil

Personalised recommendations